Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer
In this review article, we present the current knowledge on PTPN13, a class I non-receptor protein tyrosine phosphatase identified in 1994. We focus particularly on its role in cancer, where PTPN13 acts as an oncogenic protein and also a tumor suppressor. To try to understand these apparent contradi...
Main Authors: | Soha Mcheik, Leticia Aptecar, Peter Coopman, Véronique D’Hondt, Gilles Freiss |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/12/1659 |
Similar Items
-
Polymorphisms in Protein Tyrosine Phosphatase Non-receptor Type 2 and 22 (PTPN2/22) Are Linked to Hyper-Proliferative T-Cells and Susceptibility to Mycobacteria in Rheumatoid Arthritis
by: Robert C. Sharp, et al.
Published: (2018-01-01) -
Clinicopathological significance of PTPN12 expression in human breast cancer
by: Yuan Xunyi, et al.
Published: (2012-12-01) -
METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression
by: Wei Peng, et al.
Published: (2024-07-01) -
Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma
by: Caroline E. Nunes-Xavier, et al.
Published: (2019-12-01) -
Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies
by: Robert J. Salmond
Published: (2024-01-01)